Byung Cheol Ahn

This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Dobeel Corporation, Cha Vaccine Research Institute Co., Ltd. Active years: 2006-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung Cheol Ahn. Retrieved from https://idiyas.com/inventor/byung-cheol-ahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 28(Granted Patents)

Location History:

Kyonggi-Do, KR (2006)
Yongin-Si, KR (2012)
Gyeonggi-do, KR (2012 - 2023)

Company Filing History:

Cha Vaccine Research Institute Co., Ltd

patent

Years Active: 2006-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11612650 - Vaccine adjuvant comprising lipopeptide-inserted liposome as effective ingredient and use thereof (2023-03-28),

2. 8216595 - Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant (2012-07-10),

3. 8216589 - HBV vaccine and a process of preparing the same (2012-07-10),

4. 8173599 - Spray-dried collectin compositions and process for preparing the same (2012-05-08),

5. 7135338 - Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism (2006-11-14),

Title: Byung Cheol Ahn: Innovator in Vaccine Development

Introduction

Byung Cheol Ahn is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine development, holding a total of 5 patents. His work focuses on creating innovative vaccine compositions that enhance immune responses.

Latest Patents

Among his latest patents is a vaccine adjuvant comprising lipopeptide-inserted liposome as an effective ingredient. This invention relates to a recombinant herpes zoster vaccine that utilizes liposomes and lipopeptides. The vaccine composition, prepared using Lipo-Pam, induces both cell-mediated and humoral immune responses, making it commercially valuable. Another notable patent is for an HBV vaccine that includes the entire hepatitis B surface antigen, forming virus-like particles. This multi-antigen vaccine is designed to provide various epitopes and has excellent immunogenicity, promoting strong immune responses.

Career Highlights

Throughout his career, Byung Cheol Ahn has worked with notable organizations such as Dobeel Corporation and Cha Vaccine Research Institute Co., Ltd. His experience in these companies has contributed to his expertise in vaccine research and development.

Collaborations

Byung Cheol Ahn has collaborated with esteemed colleagues, including Hong Mo Moon and Jung Sun Yum. These partnerships have furthered his research and innovation in the field of vaccines.

Conclusion

Byung Cheol Ahn is a distinguished inventor whose work in vaccine development has the potential to significantly impact public health. His innovative approaches and collaborations continue to advance the field of immunology.

Profile summary based on public USPTO records.